ABSTRACT Background Obesity is a major risk factor for cardiovascular disease, but traditional measures like BMI and waist circumference have limitations. New indices, BRI and ABSI
BACKGROUND AND AIMS: We characterized body-composition heterogeneity in treatment-naive type 2 diabetes (T2DM) using dual-energy X-ray absorptiometry (DXA), and assessed whether cl
INTRODUCTION: Prediabetes is increasingly recognised as a stage at which cardiovascular and renal dysfunction begin to develop despite the absence of overt metabolic disease. The m
INTRODUCTION: Obesity substantially influences clinical and metabolic manifestations of polycystic ovary syndrome (PCOS). However, differences in clinical, metabolic, and hormonal
Secondary analysis of a randomized controlled trial showing significant associations between maternal vitamin D deficiency and altered lipid and ketone metabolism in pregnancy and cord blood, but mechanism remains unclear and clinical outcomes not reported.
A narrative review synthesizing mechanisms and clinical evidence for obesity pharmacotherapy combinations, offering expert interpretation of existing trials to inform clinical practice rather than reporting original trial results.